Pacific Biosciences Of California (PACB) Total Liabilities (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Total Liabilities of $780.0 million for Q1 2026, up 1.41% year-over-year from $769.2 million in Q1 2025, and little changed quarter-over-quarter from $778.7 million in Q4 2025.
Pacific Biosciences Of California (PACB) Total Liabilities (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Total Liabilities history runs 17 years deep, the most recent figure standing at $780.0 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 1.41% year-over-year to $780.0 million; the TTM figure through Mar 2026 stood at $780.0 million (up 1.41% YoY), while the FY2025 annual figure was $778.7 million, up 3.3% from the prior year.
- Total Liabilities for Q1 2026 stood at $780.0 million, roughly flat from $778.7 million in the prior quarter.
- The five-year high for Total Liabilities was $1.2 billion in Q2 2023, with the low at $753.9 million in Q4 2024.
- The 5-year median for Total Liabilities is $1.0 billion (2024), against an average of $1.0 billion.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 37126.29% in 2022, then dropped 27.84% in 2024.
- Pacific Biosciences Of California's Total Liabilities stood at $1.2 billion in 2022, then retreated by 13.24% to $1.0 billion in 2023, then decreased by 27.84% to $753.9 million in 2024, then gained by 3.3% to $778.7 million in 2025, then increased by 0.16% to $780.0 million in 2026.
- Business Quant data shows PACB's Total Liabilities at $780.0 million in Q1 2026, $778.7 million in Q4 2025, and $767.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 785.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 785.06 Mn |
| Mar 31, 2026 | 780.00 Mn |
| Dec 31, 2025 | 778.73 Mn |
| Sep 30, 2025 | 767.07 Mn |
| Jun 30, 2025 | 763.98 Mn |
| Mar 31, 2025 | 769.15 Mn |
| Dec 31, 2024 | 753.85 Mn |
| Sep 30, 2024 | 996.93 Mn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.19 Bn |
| Mar 31, 2022 | 1.20 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 20, 2021 | 3.20 Mn |